El Paso Cancer Treatment Ctr

El Paso, Texas 79915

0 studies enrolling now · 11 studies all time

What they study most

Androgen-independent Prostate Cancer, Breast Cancer, Gastric Cancer Adenocarcinoma Metastatic, Metastatic Breast Cancer, Metastatic Colorectal Cancer, Metastatic Prostate Cancer, Non-Hodgkin's Lymphoma, Rectal Cancer

Studies at this site

• PhII ICb With/Without Erbitux in MBC Pts — Running, not enrolling
• TAC Versus TC for Adjuvant Breast Cancer — Completed
• Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal Cancer — Completed
• Phase II Sunitinib Prog Met AIPC — Completed
• Mitoxantrone ± Cetuximab 2nd Line Androgen Independent Prostate Cancer (AIPC) — Completed
• Docetaxel+Oxali+/-Cetux Met Gastric/GEJ — Completed
• Pre-op Rectal ChemoRad +/- Cetuximab — Completed
• Adj TC + Herceptin Early Stage Breast Cancer — Completed
• Doxil & Carboplatin Plus HER2+ in Metastatic Breast Cancer — Completed
• A Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1) Administered Intravenously to Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer — Completed
• Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for Non-Hodgkin's Lymphoma — Stopped early